查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1867547

微针给药系统：全球市场份额和排名、总收入和需求预测（2025-2031年）

Microneedle Drug Delivery Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 117 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球微针药物输送系统市场规模估计为 5.12 亿美元，预计到 2031 年将达到 13.35 亿美元，在预测期（2025-2031 年）内复合年增长率为 15.2%。

微针给药系统是一种创新且无痛的给药技术，它透过微米级针头穿透皮肤表层，精准地将药物输送至目标部位。该系统结合了微纳加工技术和控释技术，能够有效地递送疫苗、生物製药、小分子药物等，显着提高药物的生物利用度和患者依从性。与传统注射相比，微针系统可减轻疼痛并降低交叉感染的风险，从而实现自我给药和大规模疫苗宣传活动。随着个人化医疗和智慧医疗设备的兴起，微针给药系统在慢性病管理、疫苗接种和美容医学领域展现出巨大的潜力，有望成为推动医疗创新的重要力量。

微针给药系统市场主要受两大驱动力推动：全球医疗需求的成长和技术进步。疫苗接种量的激增，尤其是在公共卫生措施和疫苗接种计划的推动下，加速了无痛高效给药技术的应用。製药和医疗设备製造商正加大研发投入，以实现产品多元化并拓展应用范围。政策对创新给药技术的支持以及患者对非侵入性治疗的偏好，共同推动了市场强劲成长。此外，向慢性病管理和美容医学等新兴领域的拓展也显着提升了市场潜力。儘管前景广阔，微针给药系统仍面临许多挑战。技术复杂性和高昂的製造成本限制了其大规模商业化。药物与材料的相容性问题，以及给药效率和剂量控制稳定性等问题，仍需进一步优化。冗长的监管核准流程和各国标准的不统一，也阻碍了其全球扩张。市场对安全性和长期疗效的日益关注，要求品管和临床检验持续改善。教育程度和患者接受度也显着影响市场渗透率。下游需求正朝着多元化和个人化方向发展。随着数位医疗和远端医疗的发展，微针系统正日益整合智慧监测和数据分析功能，以提高治疗精准度和病患体验。疫苗和生物製药的快速供应需求推动了物流和供应链管理的创新。在慢性病管理领域，微针系统可实现便利的自我给药和疗效监测。美容医疗市场对安全、无痛、微创解决方案的持续需求，推动了产品创新和市场扩张。整体而言，下游需求正从单一的给药功能整合到一体化的健康管理平台。

本报告旨在按地区/国家、类型和应用对全球微针药物输送系统市场进行全面分析，重点关注总收入、市场份额和主要企业的排名。

本报告以销售收入为指标，对微针给药系统市场规模、估算和预测进行了呈现，以2024年为基准年，并涵盖了2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法，帮助读者制定微针给药系统业务和成长策略，评估市场竞争情况，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • KINDEVA
  • Zosano Pharma
  • Becton-Dickinson（BD）Technologies
  • Nanopass Technologies
  • Corium
  • Valeritas
  • Nitto
  • Microdermics
  • TheraJect, Inc
  • Vaxxas
  • Lohmann Therapie-Systeme AG

按类型分類的细分市场

  • 中空微针技术
  • 固体微针技术
  • 溶解性微针技术

应用领域

  • 药物输送
  • 疫苗接种

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Microneedle Drug Delivery Systems was estimated to be worth US$ 512 million in 2024 and is forecast to a readjusted size of US$ 1335 million by 2031 with a CAGR of 15.2% during the forecast period 2025-2031.

Microneedle Drug Delivery Systems represent an innovative and painless drug administration technology that delivers medication precisely through micron-scale needles penetrating the skin's outer layer. Combining micro-nanofabrication and controlled drug release technologies, these systems efficiently deliver vaccines, biologics, small molecule drugs, and more, significantly enhancing drug bioavailability and patient compliance. Compared to conventional injections, microneedle systems reduce pain and the risk of cross-contamination, enabling self-administration and large-scale immunization campaigns. With the rise of personalized medicine and smart healthcare devices, microneedle drug delivery systems show vast potential in chronic disease management, vaccination, and aesthetic medicine, positioning themselves as a key driver of medical innovation.

The microneedle drug delivery systems market benefits from the dual drivers of rising global healthcare demands and technological advancements. The surge in vaccine administration, especially driven by public health initiatives and immunization programs, accelerates the adoption of painless and efficient delivery technologies. Pharmaceutical companies and medical device manufacturers increase R&D investments to diversify products and expand applications. Policy support for innovative drug delivery technologies and patient preference for non-invasive treatments inject strong growth momentum. Additionally, penetration into emerging fields like chronic disease management and aesthetic medicine significantly broadens market potential.Despite promising prospects, microneedle drug delivery systems face multiple challenges. Technical complexity and high manufacturing costs limit large-scale commercialization. Compatibility issues between drugs and materials, as well as stability in delivery efficiency and dosage control, require further optimization. Regulatory approval processes are lengthy, and inconsistent standards across countries increase difficulties in global product rollout. Rising market concerns over safety and long-term efficacy demand continuous improvements in quality control and clinical validation. Education and patient acceptance also critically affect market penetration.Downstream demand is moving toward diversification and personalization. With the development of digital health and telemedicine, microneedle systems increasingly integrate intelligent monitoring and data analytics to enhance treatment precision and patient experience. The rapid delivery needs of vaccines and biologics drive innovations in logistics and supply chain management. In chronic disease management, microneedle systems offer convenient self-administration and efficacy monitoring. The aesthetic medicine market's ongoing demand for safe and painless minimally invasive solutions propels product innovation and market expansion. Overall, downstream demand is evolving from single delivery functions to integrated health management platforms.

This report aims to provide a comprehensive presentation of the global market for Microneedle Drug Delivery Systems, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Microneedle Drug Delivery Systems by region & country, by Type, and by Application.

The Microneedle Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microneedle Drug Delivery Systems.

Market Segmentation

By Company

  • KINDEVA
  • Zosano Pharma
  • Becton-Dickinson(BD)Technologies
  • Nanopass Technologies
  • Corium
  • Valeritas
  • Nitto
  • Microdermics
  • TheraJect, Inc
  • Vaxxas
  • Lohmann Therapie-Systeme AG

Segment by Type

  • Hollow Microneedle Technology
  • Solid Microneedle Technology
  • Dissolving Microneedles Technology

Segment by Application

  • Drug Delivery
  • Vaccine Delivery

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Microneedle Drug Delivery Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Microneedle Drug Delivery Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Microneedle Drug Delivery Systems in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Microneedle Drug Delivery Systems Product Introduction
  • 1.2 Global Microneedle Drug Delivery Systems Market Size Forecast (2020-2031)
  • 1.3 Microneedle Drug Delivery Systems Market Trends & Drivers
    • 1.3.1 Microneedle Drug Delivery Systems Industry Trends
    • 1.3.2 Microneedle Drug Delivery Systems Market Drivers & Opportunity
    • 1.3.3 Microneedle Drug Delivery Systems Market Challenges
    • 1.3.4 Microneedle Drug Delivery Systems Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Microneedle Drug Delivery Systems Players Revenue Ranking (2024)
  • 2.2 Global Microneedle Drug Delivery Systems Revenue by Company (2020-2025)
  • 2.3 Key Companies Microneedle Drug Delivery Systems Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Microneedle Drug Delivery Systems Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Microneedle Drug Delivery Systems
  • 2.6 Microneedle Drug Delivery Systems Market Competitive Analysis
    • 2.6.1 Microneedle Drug Delivery Systems Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Microneedle Drug Delivery Systems Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedle Drug Delivery Systems as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Hollow Microneedle Technology
    • 3.1.2 Solid Microneedle Technology
    • 3.1.3 Dissolving Microneedles Technology
  • 3.2 Global Microneedle Drug Delivery Systems Sales Value by Type
    • 3.2.1 Global Microneedle Drug Delivery Systems Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Microneedle Drug Delivery Systems Sales Value, by Type (2020-2031)
    • 3.2.3 Global Microneedle Drug Delivery Systems Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Drug Delivery
    • 4.1.2 Vaccine Delivery
  • 4.2 Global Microneedle Drug Delivery Systems Sales Value by Application
    • 4.2.1 Global Microneedle Drug Delivery Systems Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Microneedle Drug Delivery Systems Sales Value, by Application (2020-2031)
    • 4.2.3 Global Microneedle Drug Delivery Systems Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Microneedle Drug Delivery Systems Sales Value by Region
    • 5.1.1 Global Microneedle Drug Delivery Systems Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Microneedle Drug Delivery Systems Sales Value by Region (2020-2025)
    • 5.1.3 Global Microneedle Drug Delivery Systems Sales Value by Region (2026-2031)
    • 5.1.4 Global Microneedle Drug Delivery Systems Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 5.2.2 North America Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 5.3.2 Europe Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Microneedle Drug Delivery Systems Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 5.5.2 South America Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Microneedle Drug Delivery Systems Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Microneedle Drug Delivery Systems Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 6.3.2 United States Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Microneedle Drug Delivery Systems Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 6.4.2 Europe Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Microneedle Drug Delivery Systems Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 6.5.2 China Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Microneedle Drug Delivery Systems Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 6.6.2 Japan Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Microneedle Drug Delivery Systems Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 6.7.2 South Korea Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Microneedle Drug Delivery Systems Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Microneedle Drug Delivery Systems Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Microneedle Drug Delivery Systems Sales Value, 2020-2031
    • 6.9.2 India Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Microneedle Drug Delivery Systems Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 KINDEVA
    • 7.1.1 KINDEVA Profile
    • 7.1.2 KINDEVA Main Business
    • 7.1.3 KINDEVA Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.1.4 KINDEVA Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.1.5 KINDEVA Recent Developments
  • 7.2 Zosano Pharma
    • 7.2.1 Zosano Pharma Profile
    • 7.2.2 Zosano Pharma Main Business
    • 7.2.3 Zosano Pharma Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.2.4 Zosano Pharma Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Zosano Pharma Recent Developments
  • 7.3 Becton-Dickinson(BD)Technologies
    • 7.3.1 Becton-Dickinson(BD)Technologies Profile
    • 7.3.2 Becton-Dickinson(BD)Technologies Main Business
    • 7.3.3 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.3.4 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Becton-Dickinson(BD)Technologies Recent Developments
  • 7.4 Nanopass Technologies
    • 7.4.1 Nanopass Technologies Profile
    • 7.4.2 Nanopass Technologies Main Business
    • 7.4.3 Nanopass Technologies Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.4.4 Nanopass Technologies Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Nanopass Technologies Recent Developments
  • 7.5 Corium
    • 7.5.1 Corium Profile
    • 7.5.2 Corium Main Business
    • 7.5.3 Corium Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.5.4 Corium Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Corium Recent Developments
  • 7.6 Valeritas
    • 7.6.1 Valeritas Profile
    • 7.6.2 Valeritas Main Business
    • 7.6.3 Valeritas Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.6.4 Valeritas Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Valeritas Recent Developments
  • 7.7 Nitto
    • 7.7.1 Nitto Profile
    • 7.7.2 Nitto Main Business
    • 7.7.3 Nitto Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.7.4 Nitto Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Nitto Recent Developments
  • 7.8 Microdermics
    • 7.8.1 Microdermics Profile
    • 7.8.2 Microdermics Main Business
    • 7.8.3 Microdermics Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.8.4 Microdermics Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Microdermics Recent Developments
  • 7.9 TheraJect, Inc
    • 7.9.1 TheraJect, Inc Profile
    • 7.9.2 TheraJect, Inc Main Business
    • 7.9.3 TheraJect, Inc Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.9.4 TheraJect, Inc Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.9.5 TheraJect, Inc Recent Developments
  • 7.10 Vaxxas
    • 7.10.1 Vaxxas Profile
    • 7.10.2 Vaxxas Main Business
    • 7.10.3 Vaxxas Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.10.4 Vaxxas Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Vaxxas Recent Developments
  • 7.11 Lohmann Therapie-Systeme AG
    • 7.11.1 Lohmann Therapie-Systeme AG Profile
    • 7.11.2 Lohmann Therapie-Systeme AG Main Business
    • 7.11.3 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Products, Services and Solutions
    • 7.11.4 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Lohmann Therapie-Systeme AG Recent Developments

8 Industry Chain Analysis

  • 8.1 Microneedle Drug Delivery Systems Industrial Chain
  • 8.2 Microneedle Drug Delivery Systems Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Microneedle Drug Delivery Systems Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Microneedle Drug Delivery Systems Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Microneedle Drug Delivery Systems Market Trends
  • Table 2. Microneedle Drug Delivery Systems Market Drivers & Opportunity
  • Table 3. Microneedle Drug Delivery Systems Market Challenges
  • Table 4. Microneedle Drug Delivery Systems Market Restraints
  • Table 5. Global Microneedle Drug Delivery Systems Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Microneedle Drug Delivery Systems Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Microneedle Drug Delivery Systems Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Microneedle Drug Delivery Systems Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Microneedle Drug Delivery Systems
  • Table 10. Global Microneedle Drug Delivery Systems Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedle Drug Delivery Systems as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Microneedle Drug Delivery Systems Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Microneedle Drug Delivery Systems Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Microneedle Drug Delivery Systems Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Microneedle Drug Delivery Systems Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Microneedle Drug Delivery Systems Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Microneedle Drug Delivery Systems Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Microneedle Drug Delivery Systems Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Microneedle Drug Delivery Systems Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Microneedle Drug Delivery Systems Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Microneedle Drug Delivery Systems Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Microneedle Drug Delivery Systems Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Microneedle Drug Delivery Systems Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Microneedle Drug Delivery Systems Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Microneedle Drug Delivery Systems Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Microneedle Drug Delivery Systems Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Microneedle Drug Delivery Systems Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Microneedle Drug Delivery Systems Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Microneedle Drug Delivery Systems Sales Value, (2026-2031) & (US$ Million)
  • Table 31. KINDEVA Basic Information List
  • Table 32. KINDEVA Description and Business Overview
  • Table 33. KINDEVA Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of KINDEVA (2020-2025)
  • Table 35. KINDEVA Recent Developments
  • Table 36. Zosano Pharma Basic Information List
  • Table 37. Zosano Pharma Description and Business Overview
  • Table 38. Zosano Pharma Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Zosano Pharma (2020-2025)
  • Table 40. Zosano Pharma Recent Developments
  • Table 41. Becton-Dickinson(BD)Technologies Basic Information List
  • Table 42. Becton-Dickinson(BD)Technologies Description and Business Overview
  • Table 43. Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Becton-Dickinson(BD)Technologies (2020-2025)
  • Table 45. Becton-Dickinson(BD)Technologies Recent Developments
  • Table 46. Nanopass Technologies Basic Information List
  • Table 47. Nanopass Technologies Description and Business Overview
  • Table 48. Nanopass Technologies Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Nanopass Technologies (2020-2025)
  • Table 50. Nanopass Technologies Recent Developments
  • Table 51. Corium Basic Information List
  • Table 52. Corium Description and Business Overview
  • Table 53. Corium Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Corium (2020-2025)
  • Table 55. Corium Recent Developments
  • Table 56. Valeritas Basic Information List
  • Table 57. Valeritas Description and Business Overview
  • Table 58. Valeritas Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Valeritas (2020-2025)
  • Table 60. Valeritas Recent Developments
  • Table 61. Nitto Basic Information List
  • Table 62. Nitto Description and Business Overview
  • Table 63. Nitto Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Nitto (2020-2025)
  • Table 65. Nitto Recent Developments
  • Table 66. Microdermics Basic Information List
  • Table 67. Microdermics Description and Business Overview
  • Table 68. Microdermics Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Microdermics (2020-2025)
  • Table 70. Microdermics Recent Developments
  • Table 71. TheraJect, Inc Basic Information List
  • Table 72. TheraJect, Inc Description and Business Overview
  • Table 73. TheraJect, Inc Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of TheraJect, Inc (2020-2025)
  • Table 75. TheraJect, Inc Recent Developments
  • Table 76. Vaxxas Basic Information List
  • Table 77. Vaxxas Description and Business Overview
  • Table 78. Vaxxas Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Vaxxas (2020-2025)
  • Table 80. Vaxxas Recent Developments
  • Table 81. Lohmann Therapie-Systeme AG Basic Information List
  • Table 82. Lohmann Therapie-Systeme AG Description and Business Overview
  • Table 83. Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Microneedle Drug Delivery Systems Business of Lohmann Therapie-Systeme AG (2020-2025)
  • Table 85. Lohmann Therapie-Systeme AG Recent Developments
  • Table 86. Key Raw Materials Lists
  • Table 87. Raw Materials Key Suppliers Lists
  • Table 88. Microneedle Drug Delivery Systems Downstream Customers
  • Table 89. Microneedle Drug Delivery Systems Distributors List
  • Table 90. Research Programs/Design for This Report
  • Table 91. Key Data Information from Secondary Sources
  • Table 92. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Microneedle Drug Delivery Systems Product Picture
  • Figure 2. Global Microneedle Drug Delivery Systems Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Microneedle Drug Delivery Systems Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Microneedle Drug Delivery Systems Report Years Considered
  • Figure 5. Global Microneedle Drug Delivery Systems Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Microneedle Drug Delivery Systems Revenue in 2024
  • Figure 7. Microneedle Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Hollow Microneedle Technology Picture
  • Figure 9. Solid Microneedle Technology Picture
  • Figure 10. Dissolving Microneedles Technology Picture
  • Figure 11. Global Microneedle Drug Delivery Systems Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 12. Global Microneedle Drug Delivery Systems Sales Value Market Share by Type, 2024 & 2031
  • Figure 13. Product Picture of Drug Delivery
  • Figure 14. Product Picture of Vaccine Delivery
  • Figure 15. Global Microneedle Drug Delivery Systems Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 16. Global Microneedle Drug Delivery Systems Sales Value Market Share by Application, 2024 & 2031
  • Figure 17. North America Microneedle Drug Delivery Systems Sales Value (2020-2031) & (US$ Million)
  • Figure 18. North America Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 19. Europe Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 20. Europe Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Asia Pacific Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Asia Pacific Microneedle Drug Delivery Systems Sales Value by Region (%), 2024 VS 2031
  • Figure 23. South America Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. South America Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 25. Middle East & Africa Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. Middle East & Africa Microneedle Drug Delivery Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Key Countries/Regions Microneedle Drug Delivery Systems Sales Value (%), (2020-2031)
  • Figure 28. United States Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. United States Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 30. United States Microneedle Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
  • Figure 31. Europe Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Europe Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 33. Europe Microneedle Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
  • Figure 34. China Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. China Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 36. China Microneedle Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
  • Figure 37. Japan Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. Japan Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 39. Japan Microneedle Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
  • Figure 40. South Korea Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. South Korea Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 42. South Korea Microneedle Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
  • Figure 43. Southeast Asia Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. Southeast Asia Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 45. Southeast Asia Microneedle Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
  • Figure 46. India Microneedle Drug Delivery Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. India Microneedle Drug Delivery Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 48. India Microneedle Drug Delivery Systems Sales Value by Application (%), 2024 VS 2031
  • Figure 49. Microneedle Drug Delivery Systems Industrial Chain
  • Figure 50. Microneedle Drug Delivery Systems Manufacturing Cost Structure
  • Figure 51. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed